Chemotherapy-Induced Rhesus Blood Group Switch in Pleomorphic Sarcoma Patient during Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) Chemotherapy Protocol, Cycle 5
Riani Widiyastuti & Edward Kurnia Setiawan Limijadi · Journal of Advances in Medicine and Medical Research · 2023
Introduction: Changes in Rhesus blood group during cancer treatment are very rare. The Rhesus blood group is a genetic characteristic that usually remains for a lifetime. In this case, a child experiences a Rhesus change during treatment of pleomorphic sarcoma using Non Rhabdomyo...
Open access
Research Article
10.9734/jammr/2023/v35i215216